{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > GPCR & G Protein > Azilsartan MedoxomilCAS：863031-21-4
Molecular Formula：C30H24N4O8
Molecular Weight：568.53
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 863031-21-4 |
| Name | Azilsartan Medoxomil |
| Molecular Formula | C30H24N4O8 |
| Molecular Weight | 568.53 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 1308068-626-2 |
| MDL | MFCD19443688 |
| SMILES | O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C5=NC(ON5)=O)C=C3)=CC=C1)OCC6=C(C)OC(O6)=O |
| Target Point | Angiotensin Receptor（AT1 receptor） |
| Passage | GPCR & G Protein |
| Background | Azilsartan Medoxomil is a potent angiotensin II type 1 (AT1) receptor antagonist that inhibits RAAS with >10,000-fold selectivity over AT2 |
| Biological Activity | Azilsartan Medoxomil (TAK-491)是一种有效的angiotensin II type 1 (AT1) receptor（血管紧张素II 1型受体）拮抗剂，抑制RAAS比作用于AT2选择性高10，000倍以上，用于治疗高血压。[1-2] |
| Data Literature Source | [1] Ojima M，et al. J Pharmacol Exp Ther，2011，336(3)，801-808. [2] Zaiken K，et al. Clin Ther，2011，33(11)，1577-1589. |
| Unit | Bottle |
| Specification | 5mg 10mg 20mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
